Last updated on June 1, 2026
If you are concerned about undergoing ssurgical grafting surgery for Peyronie’s Disease (PD) and are considering alternative treatments, Focused ShockWave Therapy (FSWT) may offer an effective option. FSWT is designed to help reduce curvature and alleviate discomfort.
Exploring Surgical Grafting for Peyronie’s Disease
Surgical grafting is typically recommended for Peyronie’s Disease (PD) when the condition has remained stable for at least three months—meaning there has been no increase in pain or worsening of the deformity. This stability is often observed around twelve months after the onset of symptoms, particularly when the deformity has impacted the ability to engage in intimacy.
Research outcomes from surgical grafting for Peyronie’s Disease (PD) have shown mixed results. Some studies observed a decrease in straightness when comparing results at 6 months versus 5 years, and a majority of patients reported dissatisfaction with their surgical outcomes. Researchers continue to investigate optimal graft materials for sealing tunical defects, focusing on those less prone to infection and bleeding while preserving function. Grafting materials from sources such as porcine and bovine tissue are commonly used.
Research Outcomes on Surgical Grafting for Peyronie’s Disease
Research outcomes from surgical grafting for Peyronie’s Disease (PD) have shown mixed results. Some studies observed a decrease in straightness when comparing results at 6 months versus 5 years, and a majority of patients reported dissatisfaction with their surgical outcomes. Researchers continue to investigate optimal graft materials for sealing tunical defects, focusing on those less prone to infection and bleeding while preserving function. Grafting materials from sources such as porcine and bovine tissue are commonly used.
Written By:
Charles Turner
Charles Turner is a seasoned Management Consultant with associations with a range of international medical companies including GlaxoSmithKline and Bristol Myers Squibb.
He is responsible for the operational, strategic, and clinical excellence of MansMatters as well as the Peyronie’s disease research and development programmes.
Reviewed by:
Mr. Leon Alamshan
A graduate of St. George’s Medical School, he has developed innovative treatment protocols that have supported improved quality of life for 1000’s of patients worldwide.
